“Dupilumab-Treated Patients With Prurigo Nodularis Experience Improvements in Itch and Skin Pain: 6-Month Results From the RELIEVE-PN Study”, J of Skin, vol. 9, no. 6, p. s715, Nov. 2025, doi: 10.25251/ayd9p145.